Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 phase III study: Japan clinical oncology group study (JCOG 0701)

被引：7

作者：

Nakamura, Kenichi ^{[2
]}

Kodaira, Takeshi ^{[1
]}

Shikama, Naoto ^{[3
]}

Kagami, Yoshikazu ^{[4
]}

Ishikura, Satoshi ^{[2
]}

Shibata, Taro ^{[2
]}

Hiraoka, Masahiro ^{[5
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan

[2] Natl Canc Ctr, Clin Trials & Practice Support Div, Ctr Canc Control & Informat Serv, Tokyo 104, Japan

[3] Shinshu Univ, Dept Radiol, Sch Med, Nagano, Japan

[4] Natl Canc Ctr, Div Radiat Oncol, Tokyo, Japan

[5] Kyoto Univ Hosp, Dept Radiat Oncol & Image Appl Therapy, Kyoto 606, Japan

来源：

JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 38卷 / 05期

关键词：

laryngeal neoplasms; radiotherapy; dose fractionation; clinical trials; phase III;

D O I：

10.1093/jjco/hyn025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A randomized Phase III study was started in Japan to demonstrate the non-inferiority of survival of accelerated fractionation radiation therapy (2.4 Gy/fr) with conventional fractionation radiation therapy (2 Gy/fr) in patients with T1-2N0M0 glottic cancer. This study began in September 2007, and a total of 360 patients will be accrued from 22 institutions within 4 years. The primary endpoint is 3-year progression-free survival (PFS). The secondary endpoints are overall survival, local progression-free survival, disease-free survival, survival with preserved voice function, complete response rate, proportion of treatment completion and adverse events.

引用

页码：387 / 389

页数：3

共 50 条

[1] Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study JCOG0701)
Kodaira, T.
Kagami, Y.
Shibata, T.
Shikama, N.
Nishimura, Y.
Ishikura, S.
Nakamura, K.
Saito, Y.
Matsumoto, Y.
Teshima, T.
Ito, Y.
Akimoto, T.
Nakata, K.
Toshiyasu, T.
Nakagawa, K.
Nagata, Y.
Nishimura, T.
Uno, T.
Kataoka, M.
Yorozu, A.
Hiraoka, M.
[J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 992 - 997
[2] Final Analysis of a Randomized Phase III Trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG0701)
Kodaira, T.
Kagami, Y.
Shibata, T.
Shikama, N.
Hiraoka, M.
Nishimura, Y.
Ishikura, S.
Nakamura, K.
Saito, Y.
Matsumoto, Y.
Konishi, K.
Ito, Y.
Akimoto, T.
Nakata, K.
Toshiyasu, T.
Nakagawa, K.
Nagata, Y.
Nishimura, T.
Uno, T.
Kataoka, M.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 940 - 940
[3] Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study
Kachhwaha, Avni
Jakhar, Shankar Lal
Syiem, Tanya
Sharma, Neeti
Kumar, Harvinder Singh
Sharma, Ajay
[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1499 - 1502
[4] Chemoradiation or Altered Fractionation for T2N0M0 Glottic Cancer
Ahamad, A.
Salenius, S.
Ross, R.
Selvaraj, R. N.
Fernandez, E.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E201 - E201
[5] A Phase 1 Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC): Japan Clinical Oncology Group Study (JCOG0702)
Onimaru, R.
Shirato, H.
Shibata, T.
Hiraoka, M.
Ishikura, S.
Onishi, H.
Karasawa, K.
Matsuo, Y.
Kokubo, M.
Shioyama, Y.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S10 - S10
[6] Results of a Phase II Study of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer by Japan Clinical Oncology Group (JCOG0403)
Hiraoka, M.
Nagata, Y.
Shibata, T.
Onishi, H.
Kokubo, M.
Karasawa, K.
Shioyama, Y.
Onimaru, R.
Kunieda, E.
Ishikura, S.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S502 - S503
[7] Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer
Murakami, Naoya
Mori, Taisuke
Machida, Ryunosuke
Kodaira, Takeshi
Ito, Yoshinori
Shikama, Naoto
Konishi, Koji
Matsumoto, Yasuo
Murakami, Yuji
Nakamura, Naoki
Yamashita, Hideomi
Yorozu, Atsunori
Yoshimura, Michio
Inoue, Koichi
Nozaki, Miwako
Ishikura, Satoshi
Itami, Jun
Nishimura, Yasumasa
Kagami, Yoshikazu
[J]. LARYNGOSCOPE, 2021, 131 (07): : 1522 - 1527
[8] Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
Nagata, Yasushi
Hiraoka, Masahiro
Shibata, Taro
Onishi, Hiroshi
Kokubo, Masaki
Karasawa, Katsuyuki
Shioyama, Yoshiyuki
Onimaru, Rikiya
Kozuka, Takuyo
Kunieda, Etsuo
Saito, Tsutomu
Nakagawa, Keiichi
Hareyama, Masato
Takai, Yoshihiro
Hayakawa, Kazushige
Mitsuhashi, Norio
Ishikura, Satoshi
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (05): : 989 - 996
[9] Stereotactic Body Radiation Therapy For T1N0M0 Non-small Cell Lung Cancer: First Report for Inoperable Population of a Phase II Trial by Japan Clinical Oncology Group (JCOG 0403)
Nagata, Y.
Hiraoka, M.
Shibata, T.
Onishi, H.
Kokubo, M.
Karasawa, K.
Shioyama, Y.
Onimaru, R.
Kozuka, T.
Ishikura, S.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S46 - S46
[10] RADIATION-THERAPY FOR EARLY GLOTTIC CANCER (T1N0M0) .2. PROSPECTIVE RANDOMIZED STUDY CONCERNING RADIATION-FIELD
TESHIMA, T
CHATANI, M
INOUE, T
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (01): : 119 - 123

← 1 2 3 4 5 →